Get started
Author

Sheng Ma

Observed names: Ma, Sheng, SHENG MA
Observed institutions: Huanggang Normal University, University of Oradea, Guangdong Medical College, Soochow University, Chinese Academy of Sciences, Sheng Jing Hospital, Soochow University, Xianning Central Hospital, Hubei University of Science and Technology, Shanghai Institute of Materia Medica, Jiangsu Hengrui Medicine (China), First Affiliated Hospital of Soochow University, Affiliated Hospital of Guangdong Medical College Hospital, Tongji Hospital, University of Chinese Academy of Sciences, Haisco Pharmaceutical Group Co., Ltd. (China), Huazhong University of Science and Technology, Ocean University of China
ORCID: 0009-0000-8037-1474
Observed ORCIDs: 0009-0000-8037-1474, 0000-0002-0878-7587
OpenAlex ID: A5100565558
Mass balance, pharmacokinetics and pharmacodynamics of intravenous HSK3486, a novel anaesthetic, administered to healthy subjects
2020 · Yicong Bian, Hua Zhang, et al. · British Journal of Clinical Pharmacology · 162
Chrysin induces cell apoptosis via activation of the p53/Bcl-2/caspase-9 pathway in hepatocellular carcinoma cells
2016 · QINGYU ZHANG, SHENG MA, et al. · Experimental and Therapeutic Medicine · 76
PDF
Effect of the P450 oxidoreductase *28 polymorphism on the pharmacokinetics of tacrolimus in Chinese healthy male volunteers
2012 · Jing-Jing Zhang, Hua Zhang, et al. · European Journal of Clinical Pharmacology · 62
Design and Synthesis of Small Molecule RhoA Inhibitors: A New Promising Therapy for Cardiovascular Diseases?
2011 · Jing Deng, Enguang Feng, et al. · Journal of Medicinal Chemistry · 50
Dihydromyricetin Enhances the Chemo-Sensitivity of Nedaplatin via Regulation of the p53/Bcl-2 Pathway in Hepatocellular Carcinoma Cells
2015 · Lianggui Jiang, Qingyu Zhang, et al. · PLoS ONE · 45
PDF
Metabolism and disposition of pyrotinib in healthy male volunteers: covalent binding with human plasma protein
2018 · Jian Meng, Xiao-yun Liu, et al. · Acta Pharmacologica Sinica · 42
PDF
Enhancer transcription profiling reveals an enhancer RNA-driven ferroptosis and new therapeutic opportunities in prostate cancer
2025 · Sheng Ma, Zixian Wang, et al. · Signal Transduction and Targeted Therapy · 37
Pharmacokinetics, mass balance, and metabolism of [14C]vicagrel, a novel irreversible P2Y12 inhibitor in humans
2020 · Yuan-dong Zheng, Hua Zhang, et al. · Acta Pharmacologica Sinica · 29
PDF
Pharmacokinetics, Mass Balance, and Metabolism of the Novel Urate Transporter 1 Inhibitor [14C]HR011303 in Humans: Metabolism Is Mediated Predominantly by UDP-Glucuronosyltransferase
2021 · Yuandong Zheng, Hua Zhang, et al. · Drug Metabolism and Disposition · 14
PDF
Evaluation of the in vitro Chemosensitivity and Correlation with Clinical Outcomes in Lung Cancer using the ATP-TCA
2017 · Zhiyao Chen, Shichao Zhang, et al. · Anti-Cancer Agents in Medicinal Chemistry · 13
Absorption, metabolism, and excretion of [14C]YY-20394, a highly selective PI3K-Delta inhibitor in humans
2022 · Jinghua Yu, Hua Zhang, et al. · Xenobiotica · 11
Pharmacokinetics, Mass Balance and Metabolism of [14C]HSK21542, a Novel Kappa Opioid Receptor Agonist, in Humans
2023 · Jin-jie Yuan, Yi-cong Bian, et al. · European Journal of Drug Metabolism and Pharmacokinetics · 10
Mass balance study of [14C]SHR0302, a selective and potent JAK1 inhibitor in humans
2023 · Xinyu Ge, Sheng Ma, et al. · Xenobiotica · 10
The Convergence Properties of the Credibility Distribution Sequence of Fuzzy Variables
2014 · Sheng Ma · Journal of modern mathematics frontier · 10
A mass balance study of [14C]SHR6390 (dalpiciclib), a selective and potent CDK4/6 inhibitor in humans
2023 · Hua Zhang, Shu Yan, et al. · Frontiers in Pharmacology · 9
PDF
Development of Second‐Generation Small‐Molecule RhoA Inhibitors with Enhanced Water Solubility, Tissue Potency, and Significant in vivo Efficacy
2014 · Sheng Ma, Jing Deng, et al. · ChemMedChem · 9
Integrated Omics and Multicohort Analyses Identify an Enhancer Variant Linking Ferroptosis to Precision Therapy in Prostate Cancer
2025 · Sheng Ma, Yue Ge, et al. · Cancer Research · 8
Metabolite profiles and mass balance of fuzuloparib, a novel poly (ADP‐ribose) polymerase inhibitor, in subjects with advanced solid cancers
2022 · Yicong Bian, Jian Meng, et al. · British Journal of Clinical Pharmacology · 8
PDF
A retrospective study of the correlation of in vitro chemosensitivity using ATP-TCA with patient clinical outcomes in acute myeloid leukemia
2019 · Fan Xia, Sheng Ma, et al. · Cancer Chemotherapy and Pharmacology · 7
Absorption, Metabolism and Excretion of Surufatinib in Rats and Humans
2020 · Ke Li, Sheng Ma, et al. · Current Drug Metabolism · 6
Phase I, First-in-Human, Single and Multiple Ascending Dose- and Food-Effect Studies to Assess the Safety, Tolerability and Pharmacokinetics of a Novel Anti-hepatitis B Virus Drug, Bentysrepinine (Y101), in Healthy Chinese Subjects
2020 · Xiaoxue Liu, Ling Xue, et al. · Clinical Drug Investigation · 6
Existence and Multiplicity of Solutions for p-Laplacian Neumann Problems
2019 · Qin Jiang, Sheng Ma, et al. · Results in Mathematics · 5
Targeting the HSP60/p53 Axis with Extracellular Vesicle-Delivered siRNA Reprograms Glycolysis in Prostate Cancer
2025 · Meng-Yao Xu, Sheng Ma, et al. · International Journal of Biological Sciences · 4
Pharmacokinetics, mass balance, and metabolism of [14C]FCN-437c, a selective and potent CDK4/6 inhibitor in humans
2025 · Lei Gao, Sheng Ma, et al. · Cancer Chemotherapy and Pharmacology · 4
Dietary oxygenated water mitigates type 2 diabetes mellitus by modulating gut microbiota and enhancing glucose metabolism in skeletal muscle
2024 · Yue Xiao, Dongmei Yang, et al. · Food Bioscience · 3
Works count: 81
Citation count: 671
H-index: 11
I10-index: 14
Year
Topic
Type